ES2195361T3 - Peptido de union a integrina y uso del mismo. - Google Patents

Peptido de union a integrina y uso del mismo.

Info

Publication number
ES2195361T3
ES2195361T3 ES98933671T ES98933671T ES2195361T3 ES 2195361 T3 ES2195361 T3 ES 2195361T3 ES 98933671 T ES98933671 T ES 98933671T ES 98933671 T ES98933671 T ES 98933671T ES 2195361 T3 ES2195361 T3 ES 2195361T3
Authority
ES
Spain
Prior art keywords
integrine
union
peptide
same
integrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98933671T
Other languages
English (en)
Inventor
Jyrki Heino
Johanna Ivaska
Jarmo Kapyla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotie Therapies Corp
Original Assignee
Biotie Therapies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corp filed Critical Biotie Therapies Corp
Application granted granted Critical
Publication of ES2195361T3 publication Critical patent/ES2195361T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se proporcionan péptidos cíclicos que comprenden tres aminoácidos colineales, arginina-lisina-lisina (RKK) que se unen al dominio {al}2I de la integrina y que son potentes inhibidores de su interacción con los colágenos I y IV y con la laminina 1. Se proporcionan también procedimientos de uso de dichos péptidos para bloquear el funcionamiento de la integrina y para inhibir la migración celular.
ES98933671T 1997-07-11 1998-07-09 Peptido de union a integrina y uso del mismo. Expired - Lifetime ES2195361T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/893,526 US6096707A (en) 1997-07-11 1997-07-11 Integrin binding peptide and use thereof

Publications (1)

Publication Number Publication Date
ES2195361T3 true ES2195361T3 (es) 2003-12-01

Family

ID=25401719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98933671T Expired - Lifetime ES2195361T3 (es) 1997-07-11 1998-07-09 Peptido de union a integrina y uso del mismo.

Country Status (17)

Country Link
US (1) US6096707A (es)
EP (1) EP0994898B1 (es)
JP (1) JP2001509515A (es)
KR (1) KR100571046B1 (es)
CN (1) CN1262688A (es)
AT (1) ATE235510T1 (es)
AU (1) AU748134B2 (es)
BR (1) BR9810586A (es)
CA (1) CA2295219C (es)
DE (1) DE69812630T2 (es)
ES (1) ES2195361T3 (es)
HU (1) HU225326B1 (es)
NO (1) NO20000126D0 (es)
NZ (1) NZ501767A (es)
PL (1) PL338001A1 (es)
RU (1) RU2203902C2 (es)
WO (1) WO1999002551A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US7387779B2 (en) 1998-06-17 2008-06-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
US6759047B1 (en) 1998-06-17 2004-07-06 Beth Israel Deaconess Hospital Corp. Anti-angiogenic proteins and methods of use thereof
US6962974B1 (en) 1998-06-17 2005-11-08 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
KR20030080013A (ko) * 2001-02-21 2003-10-10 에자이 가부시키가이샤 인테그린 발현 억제를 통한 혈관 신생 억제제의 효과를검정하는 방법
CA2439852A1 (en) * 2001-03-02 2002-09-12 Christine Dingivan Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists
JP2005525368A (ja) * 2002-03-04 2005-08-25 メディミューン，インコーポレーテッド インテグリンαｖβ３アンタゴニストをＨＭＧ−ＣｏＡ還元酵素阻害剤またはビスフォスフォネートと併用投与する障害の予防または治療方法
CA2478239A1 (en) * 2002-03-04 2003-09-18 Medimmune, Inc. The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
EP1499352A4 (en) * 2002-04-12 2006-10-11 Medimmune Inc ANTI-INTERLEUKIN-9 RECOMBINANT ANTIBODIES
AU2003232077A1 (en) * 2002-05-06 2003-11-17 The Scripps Research Institute Cyclic peptide anti-cancer agents and methods
CA2514653A1 (en) * 2003-01-30 2004-08-12 Medimmune, Inc. Uses of integrin alphavbeta3 antagonists
JP4764818B2 (ja) 2003-04-11 2011-09-07 メディミューン，エルエルシー 組換えｉｌ−９抗体およびその使用
US7196061B2 (en) * 2003-09-10 2007-03-27 Wyeth Compounds that modulate neuronal growth and their uses
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
CA2585717A1 (en) 2004-10-27 2006-05-04 Medimmune Inc. Modulation of antibody specificity by tailoring the affinity to cognate antigens
US8987306B2 (en) * 2005-06-07 2015-03-24 The Trustees Of The University Of Pennsylvania Inhibitors of integrin alpha2beta1 based on prolyl diaminopropionic acid scaffold
WO2006133338A1 (en) * 2005-06-07 2006-12-14 The Trustees Of The University Of Pennesylvania INHIBITORS OF THE α2β1/GPIa-IIa INTEGRIN
EP1924595A2 (en) * 2005-08-12 2008-05-28 Cartela R & D AB Novel peptides and uses thereof
JP4826721B2 (ja) * 2005-08-18 2011-11-30 三菱電機株式会社 マンコンベアの制御装置
WO2007027742A2 (en) * 2005-08-31 2007-03-08 The Trustees Of The University Of Pennsylvania SMALL MOLECULE INTEGRIN α2βl/GPIa-IIa ANTAGONISTS
US7691839B2 (en) 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
WO2007072037A1 (en) * 2005-12-22 2007-06-28 Novabiotics Limited Cyclic antimicrobial peptides
US8637469B2 (en) 2006-07-11 2014-01-28 Roy C. Levitt Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
JP2010500360A (ja) 2006-08-10 2010-01-07 アルボア コーポレーション 炎症性サイトカイン阻害剤による下気道炎症疾患の局所療法
GB0618512D0 (en) * 2006-09-20 2006-11-01 Lexcicon Ltd Peptides
FI20075258A0 (fi) * 2007-04-17 2007-04-17 Biotie Therapies Corp Menetelmä integriiniinhibiittorirespondereiden seulomiseksi
WO2009052449A1 (en) * 2007-10-17 2009-04-23 University Of Southern California Novel peptides and uses thereof
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
EP2547693B1 (en) 2010-03-19 2015-03-11 H. Lee Moffitt Cancer Center & Research Institute Integrin interaction inhibitors for the treatment of cancer
JP5952840B2 (ja) * 2011-02-22 2016-07-13 レオ ファーマ アクティーゼルスカブ ケラチノサイトへの結合のための環状ペプチドおよびその結合体
WO2015048477A1 (en) 2013-09-27 2015-04-02 H. Lee Moffitt Cancer Center And Research Institute, Inc. Cyclic peptide conjugates and methods of use
JP6866296B2 (ja) * 2015-02-27 2021-04-28 ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System ポリペプチド治療及びその使用
EP3849580A4 (en) 2018-09-10 2022-06-15 Lung Therapeutics, Inc. MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THEIR USE IN THE TREATMENT OF FIBROSIS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179007A (en) * 1989-07-07 1993-01-12 The Texas A & M University System Method and vector for the purification of foreign proteins
US5710123A (en) * 1992-12-18 1998-01-20 Centocor, Inc. Peptide inhibitors of selectin binding
US5627263A (en) * 1993-11-24 1997-05-06 La Jolla Cancer Research Foundation Integrin-binding peptides
JPH10502349A (ja) * 1994-06-29 1998-03-03 テキサス・バイオテクノロジー・コーポレイシヨン インテグリンα▲下４▼β▲下１▼のＶＣＡＭ−１またはフィブロネクチンへの結合を阻害する方法

Also Published As

Publication number Publication date
PL338001A1 (en) 2000-09-25
WO1999002551A1 (en) 1999-01-21
NO20000126L (no) 2000-01-10
CA2295219A1 (en) 1999-01-21
DE69812630D1 (de) 2003-04-30
KR100571046B1 (ko) 2006-04-13
EP0994898A1 (en) 2000-04-26
DE69812630T2 (de) 2004-02-05
JP2001509515A (ja) 2001-07-24
HU225326B1 (en) 2006-09-28
CA2295219C (en) 2007-01-02
HUP0002789A3 (en) 2003-08-28
HUP0002789A2 (hu) 2000-12-28
NZ501767A (en) 2002-08-28
US6096707A (en) 2000-08-01
CN1262688A (zh) 2000-08-09
KR20010015547A (ko) 2001-02-26
EP0994898B1 (en) 2003-03-26
AU8341398A (en) 1999-02-08
AU748134B2 (en) 2002-05-30
RU2203902C2 (ru) 2003-05-10
BR9810586A (pt) 2000-09-05
NO20000126D0 (no) 2000-01-10
ATE235510T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
ES2195361T3 (es) Peptido de union a integrina y uso del mismo.
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
ES2160485B1 (es) Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
NO891711D0 (no) Hiv env-kodet peptid som er istand til aa fremkalle hiv-inhiberende antistoffer i pattedyr.
ES2196348T3 (es) Composiciones para retardar el crecimiento del cabello y el uso correspondiente.
MX9301751A (es) Acidos amido peroxicarboxilicos.
AR007737A1 (es) Un derivado de un peptido soluble, un procedimiento para su preparacion, una porcion polipeptidica del mismo, un polimero de adn, un vector de expresionreplicable, una celula huesped, un elemento peptidico modificado que se une a la membrana, una composicion farmaceutica que comprende dicho derivado y el uso
DE69734131D1 (de) Für eine elektrolumineszierende Diode verwendete Doppelschicht-Elektroneninjektionselektrode
ES2162284T3 (es) Proceso para la fabricacion de tensioactivos que contienen grupos alquilo de cadena ramificada.
PT1032555E (pt) Aminoacidos ciclicos e derivados uteis como agentes farmaceuticos
DE69736529D1 (de) Halbleiteranordnung für hochspannung
DE68923401D1 (de) Peptide mit T-Zellen-Helfer-Wirksamkeit.
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
ES2155886T3 (es) Antagonistas super activos del vip.
RS49517B (sr) PEPTID p277-ANALOZI I FARMACEUTSKI PREPARATI KOJI GA SADRZE
DE69403459T2 (de) Peptidboronsäurederivate mit protease inhibierenden aktivität
ES2193216T3 (es) Dipeptidil peptidasa iv y su procedimiento de preparacion.
BR9612115A (pt) Inibidor de proliferação de célula endotelial e processo de uso
DE69617396D1 (de) T-Zellen beeinflussende Peptide
DE69706659D1 (de) Prüfung von elektrischen anlagen
DK0624196T3 (da) Polypeptider med fibronectinbindingssteder som modulator for matrixopbygning.
EA199901074A1 (ru) Соединенный прогон с двумя или более примыкающими друг к другу с перехлестом в продольном направлении деревянными балками, а также крепежный элемент для соединения двух перехлестывающихся концевых зон деревянных балок для использования в прогоне
CU23164A3 (es) Proteina recombinante de union a aminas vasoactivas
DE69940954D1 (de) Von mage-10 oder mage-8 abgeleitete hla-a2.1-bindende oligopeptide
DE69938130D1 (de) Neue peptide